Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Poland Delivery Of An Echocardiographic Device, An Ultrasound Device And An Ultrasound Head - Case Reference Number: Z/20/pn/26 2026-09-14
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Estradiol (excluding Dafo Uta/tab), Atc G03ca03 For The Period 01.05.2630.04.28 (plus Option 1x12 Months) 2026-09-14
Poland Delivery Of Defibrillators, External Massage Devices And Electrocardiographs - Case Reference: Z/19/pn/26 2026-09-14
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Beclometasone (excl. Dafo Ihp), Atc R03ba01 For The Period 01.05.2630.04.28 2026-09-14
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Tolvaptan, Excluding Pharmaceuticals With Uniform Strengths (atc Code 2026-09-14
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Estradiol (excluding Dafo Spt), Atc G03ca03 For The Period 01.05.26 To 30.04.28 (plus Option For 1x12 Months) 2026-09-14
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Trientine (exclusively Dosage Form Hkp), Atc A16ax12 For The Period 01.05.26-30.04.28 2026-09-14
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Entrepreneurs For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal 2026-09-14
Germany Clostridium Botulinum (abobotulinum) Toxin Type A_tk, Hek, Hkk 2026-09-14
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Entrepreneurs For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal 2026-09-14
Whats app